Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Cornea
Share your love
What Is Corneal Collagen Cross-Linking?
The world of ophthalmology is constantly evolving, with innovative treatments and procedures emerging to address a wide range of eye conditions. One such cutting-edge treatment, corneal collagen cross-linking (CXL), has gained significant attention for its role in managing keratoconus, a…
Lotilaner Shows Promise for Treating Demodex Blepharitis
A team of investigators, led by Elizabeth Yeu, MD, from Virginia Eye Consultants in Norfolk, Virginia, reported the safety and efficacy of lotilaner ophthalmic solution, 0.25% (TP-03, Tarsus Pharmaceuticals Inc.), in treating Demodex blepharitis. Demodex mites are the most common…
Azalea’s First On-Eye Test of ALMA Smart Contact Lens
Azalea Vision announced the successful demonstration of the ALMA Lens, marking the debut of the first functional prototype for the Azalea smart contact lens platform. The ALMA proprietary device is designed to provide a non-surgical solution for individuals dealing with…
Connection between Keratoconus and DED
Dry eye disease is more common in people over the age of 50. Hormonal changes, especially common in women, can cause dry eye. Other medical conditions including diabetes, glaucoma, Sjogren’s syndrome, lupus, and rheumatoid arthritis can exacerbate dry eye symptoms.…
Australian Government Allocates $35M for Blindness Research
In a significant stride towards combating global corneal blindness, the Australian Government’s Medical Research Futures Fund (MRFF) has allocated a substantial sum of $35 million to BIENCO, a consortium comprising clinical, scientific, and governance experts. The University of Wollongong (UOW)…
FDA Gives Green Light to OK-101 Trial for NCP Treatment
Okyo Pharma’s first investigational new drug (IND) application for OK-101 has been cleared by the U.S. Food and Drug Administration (FDA), marking a pivotal moment in the development of potential therapies for neuropathic corneal pain. Initially proposed as an open-label…
Best 6 Advances in Cataract Surgery
Cataract surgery has undergone remarkable advancements, leading to significant improvements in patient outcomes and revolutionizing the field of ophthalmology. From advanced surgical techniques to innovative intraocular lens (IOL) options, this article explores the top six breakthroughs in cataract surgery that…
Iris Prolapse: Causes, Symptoms and Treatment
Iris prolapse is a condition wherein the iris, the colored part of the eye responsible for controlling the amount of light entering the eye, protrudes out through a surgical wound or a traumatic wound in the cornea or sclera. This…
10 Facts About Ophthalmologists and Their Work
Ophthalmologists, often referred to as eye doctors, are healthcare professionals who specialize in the diagnosis, treatment, and management of eye diseases and disorders. While we may visit them for routine eye exams or specific vision concerns, the world of ophthalmology…
Harrow Secures US and Canadian Rights to Vevye
Harrow has recently announced a significant development by entering the prescription dry eye disease treatment market. The company has successfully struck a deal to acquire the commercial rights for Vevye (cyclosporine ophthalmic solution 0.1%) in both the United States and…